logo
Plus   Neg
Share
Email

Aixtron Says CFIUS Opposes Grand Chip Deal Due To Security Concerns

AIXTRON SE (AIXG) announced Friday that the investigation period for the Committee on Foreign Investment in the United States or CFIUS to review the tender offer by Grand Chip Investment GmbH or GCI lapsed on November 17, 2016.

AIXTRON said that CFIUS informed GCI and Aixtron that there are unresolved U.S. National security concerns regarding proposed transaction. CFIUS informed parties that it plans to recommend to the U.S. President that the transaction be prohibited due to security concerns.

As a consequence thereof, CFIUS recommended the parties request withdrawal of their notice and abandon the entire transaction.

GCI and AIXTRON plan to continue to actively engage in further discussions to explore means of mitigation that may be amenable to CFIUS or the U.S.President to resolve outstanding U.S. national security concerns or to take other alternative measures that could allow the parties to proceed with the transaction.

Both, GCI and AIXTRON have decided not to follow such recommendation as a result of which the matter has been referred to the U.S. President for decision in line with CFIUS statutes.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Latam Airlines Group SA, one of the largest air carrier in South America, has filed for bankruptcy protection in New York amid the ongoing Covid-19 pandemic, which has grounded flights worldwide. This Chapter 11 filing allows Latam to work with its creditors and other stakeholders to reduce its debt,... Pizza Hut said it is giving away 500,000 free pizzas to 2020 graduates in the Unites States. The pizza chain, owned by Yum! Brands, offers one free medium 1-topping pizza to all diploma/degree earning individuals until supplies last. The company is partnering with America's dairy farmers for the offer, which can be claimed until Thursday and redeemed until June 4. Merck & Co. Inc. on Tuesday announced deals, including an acquisition and two collaborations that will enable the U.S. drugmaker to join the race to develop coronavirus vaccines and drugs. Shares of Merck were rising almost 4 percent in the pre-market. Merck said it has agreed to acquire privately-held Themis, an Austria-based company focused on vaccines and immune-modulation therapies.
RELATED NEWS
Follow RTT